IRIS
COPPOLINO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.726
EU - Europa 3.621
AS - Asia 1.667
SA - Sud America 543
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 2
Totale 9.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.640
RU - Federazione Russa 1.879
SG - Singapore 684
CN - Cina 524
BR - Brasile 476
IE - Irlanda 457
SE - Svezia 442
DE - Germania 218
HK - Hong Kong 183
UA - Ucraina 137
FR - Francia 120
FI - Finlandia 100
VN - Vietnam 90
GB - Regno Unito 84
IT - Italia 79
IN - India 45
CA - Canada 34
AR - Argentina 26
MX - Messico 24
BD - Bangladesh 23
PL - Polonia 21
CZ - Repubblica Ceca 19
IQ - Iraq 16
TR - Turchia 15
ZA - Sudafrica 15
ES - Italia 13
BE - Belgio 12
MA - Marocco 12
JP - Giappone 11
CO - Colombia 10
ID - Indonesia 10
AT - Austria 9
VE - Venezuela 8
EC - Ecuador 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
PY - Paraguay 6
NL - Olanda 5
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
NI - Nicaragua 4
NP - Nepal 4
AL - Albania 3
CR - Costa Rica 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
TN - Tunisia 3
AU - Australia 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GR - Grecia 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MN - Mongolia 1
NG - Nigeria 1
PR - Porto Rico 1
RW - Ruanda 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 9.607
Salva come PNG Salva come JPEG
Città #
Ashburn 573
Moscow 487
Dublin 457
Chandler 439
Singapore 365
Jacksonville 310
Dallas 278
Nyköping 222
Beijing 200
Hong Kong 182
San Jose 180
The Dalles 99
Council Bluffs 95
Dearborn 87
Princeton 69
Lauterbourg 67
Los Angeles 66
Cambridge 62
Medford 60
Munich 59
Des Moines 58
Ann Arbor 57
New York 50
Boardman 45
Ho Chi Minh City 34
São Paulo 34
Buffalo 27
Santa Clara 27
Bremen 24
Frankfurt am Main 23
Tianjin 21
Turku 21
Redondo Beach 20
Hanoi 19
San Mateo 19
Lancaster 18
Orem 18
Seattle 17
Belo Horizonte 16
Brooklyn 16
Helsinki 16
Warsaw 16
Brno 14
Chennai 14
Montreal 14
Woodbridge 14
Jinan 13
Brussels 12
Nanjing 12
Shanghai 12
Atlanta 11
Brasília 11
Denver 11
Düsseldorf 10
Johannesburg 10
Shenyang 10
Tokyo 10
Wilmington 10
Chicago 9
Dhaka 9
London 9
Porto Alegre 9
Rio de Janeiro 9
Bexley 8
Boston 8
Houston 8
Leawood 8
Milan 8
Ningbo 8
Poplar 8
Stockholm 8
Taizhou 8
Campinas 7
Curitiba 7
Falls Church 7
Haikou 7
Pune 7
Recife 7
Augusta 6
Guangzhou 6
Hebei 6
Hefei 6
Mexico City 6
Nanchang 6
Nuremberg 6
Querétaro 6
Riga 6
San Francisco 6
Shenzhen 6
Asunción 5
Baghdad 5
Goiânia 5
Hangzhou 5
Jiaxing 5
Manchester 5
Siracusa 5
Tashkent 5
Zhengzhou 5
Ankara 4
Baku 4
Totale 5.419
Salva come PNG Salva come JPEG
Nome #
Erythropoietin and its lost receptor. 244
A brief "update" on renal effects of caffeine 219
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 215
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 212
Dialysis and the Elderly: An Underestimated Problem. 200
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 195
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 193
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 187
Caffeine and the kidney: What evidence right now? 181
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 180
Acute cardiovascular complications of hemodialysis. 178
Impaired antiviral activity of monocytes from patients on hemodiafiltration 177
T and B lymphocytes: Chromosomic damage induced by hemodiafiltration. 177
Kidney disease and psoriasis: novel evidences beyond old concepts 177
Dialysis-related genotoxicity: Sister chromatid exchanges and DNA lesions in T and B lymphocytes of uremic patients - Genomic damage in patients on hemodiafiltration 175
Effects of haemodialysis on circulating endothelial progenitor cell count 174
Cardiovascular risk impairs circulating endothelial progenitor cells mobilization during a haemodialytic session 170
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 169
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 168
The erythropoietin and regenerative medicine: a lesson from fish 168
Cinacallcet modifies the pH of solutions in vitro: possible implications for gastro-intestinall side effects in vivo 167
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 167
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 166
Analysis of antiviral activity in monocytes obtained from dialysis patients 166
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 165
Aquaretic agents: What's beyond the treatment of hyponatremia? 162
Nephro-oncology: a link in evolution 158
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 157
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 156
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 156
Erythropoietin and its lost receptor [8] 151
Therapy with vasopressin receptor antagonists: the aquaretics 150
Neurobiological model and quality of life in discovering personality of the uremic patient. 149
Renal complications in oncohematologic patients. 146
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 142
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 142
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 142
Pregnancy in uremic patients: An eventful journey 140
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 140
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 139
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 134
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 133
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 129
Management of patients after renal graft loss: an open question for nephrologists. 129
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 122
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 121
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 120
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 120
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 110
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 108
Genomic damage in endothelial progenitor cells from uremic patients. 106
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 103
Pulmonary hypertension and erythropoietin. 103
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 103
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 95
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 95
Variations of macular thickness after haemodialysis. A study using optical coherence tomography (OCT) 93
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 92
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 89
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 83
Wernicke-Korsakoff Syndrome in End-Stage Renal Disease: A Case Report 82
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 79
NGAL: a new missing link between inflammation and uremic anemia? 77
Restoring the dysfunctional endothelium 73
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 71
Haemodialysis: An Interesting Experimental Model 71
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 67
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 45
null 39
null 20
null 16
Totale 9.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022473 0 67 4 17 30 4 20 10 4 92 71 154
2022/20231.415 127 148 58 130 107 130 7 82 569 6 38 13
2023/2024278 27 49 14 28 23 73 2 19 0 7 4 32
2024/20251.422 26 12 40 92 38 55 34 259 359 126 141 240
2025/20264.402 254 307 309 273 392 900 520 558 564 142 79 104
2026/2027416 100 316 0 0 0 0 0 0 0 0 0 0
Totale 9.648